richard_laxer

Richard Laxer

pharmafile | May 6, 2022 | Appointment | |   

Richard Laxer joins Oxford Science Enterprises as an independent non-executive director. Richard is a veteran of GE Capital, serving the company for 34 years before retiring in 2018 as the CEO and Chairman. Since leaving GE Capital, Richard has used his experience and expertise to advise companies which are using cutting-edge and innovative technologies to disrupt the financial services industry.

“I am thrilled to be joining the Board of Oxford Science Enterprises,” said Richard. “The pioneering science and technology advancing from the University of Oxford has significant potential to address some of the major global impact challenges that we face today. I am excited to support the company in its investments, and to champion these new ventures into disruptive new enterprises.” 

“I am thrilled to be joining the Board of Oxford Science Enterprises,” said Richard. “The pioneering science and technology advancing from the University of Oxford has significant potential to address some of the major global impact challenges that we face today. I am excited to support the company in its investments, and to champion these new ventures into disruptive new enterprises.” 

 

Related Content

No items found

Latest content